Dr. Seigo Izumo is a clinical cardiologist with broad background in basic research, teaching, patient care, drug discovery and drug development. He also has extensive administrative experiences in leading multidisciplinary teams in both academic and industry settings. He has held a number of senior leadership positions at universities, teaching hospitals and global pharmaceutical companies in the past.

Dr. Seigo Izumo is currently Senior Vice President, Global Head of Regenerative Medicine Unit at Takeda Pharmaceutical Company Limited. He is responsible for Takeda’s strategic initiative in regenerative medicine business. Before his current position with Takeda, he served as Senior VP & Head of Cardiovascular Therapeutics at Gilead Sciences, and VP & Global Head of Cardiovascular Research at Novartis Institute of Biomedical Research, Cambridge, MA. Prior to joining the industry, he served as Professor of Medicine at Harvard Medical School, Director of Cardiovascular Research at Beth Israel Deaconess Medical Center, Boston.

He is a board certified physician by American Board of Internal Medicine and by American Board of Cardiovascular Disease Subspecialty.